BerandaABUS • NASDAQ
add
Tekmira Pharmaceuticals
Tutup sebelumnya
$4,78
Rentang hari
$4,66 - $4,76
Rentang tahun
$2,71 - $5,10
Kapitalisasi pasar
911,62 jt USD
Volume Rata-Rata
1,24 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 529,00 rb | -60,49% |
Biaya operasional | 3,04 jt | -32,91% |
Penghasilan bersih | -7,74 jt | 60,73% |
Margin laba bersih | -1,46 rb | 0,61% |
Penghasilan per saham | -0,06 | 59,57% |
EBITDA | -8,28 jt | 51,67% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 93,70 jt | -26,68% |
Total aset | 97,71 jt | -30,43% |
Total liabilitas | 20,31 jt | -39,46% |
Total ekuitas | 77,40 jt | — |
Saham yang beredar | 192,32 jt | — |
Harga terhadap nilai buku | 11,95 | — |
Tingkat pengembalian aset | -20,63% | — |
Tingkat pengembalian modal | -24,39% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -7,74 jt | 60,73% |
Kas dari operasi | -5,82 jt | 71,95% |
Kas dari investasi | -10,02 jt | 16,41% |
Kas dari pembiayaan | 844,00 rb | -52,45% |
Perubahan kas bersih | -15,00 jt | 51,51% |
Arus kas bebas | -2,55 jt | 76,57% |
Tentang
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Didirikan
2007
Kantor pusat
Situs
Karyawan
44
